Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. - van Oosten,B.W.; Barkhof,F.; Truyen,L.; Boringa,J.B.; Bertelsmann,F.W.; von Blomberg,B.M.; Woody,J.N.; Hartung,H.P.; Polman,C.H. (Neurology, 1996)